These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

675 related items for PubMed ID: 31140385

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System.
    Trimboli P, Piccardo A, Signore A, Valabrega S, Barnabei A, Santolamazza G, Di Paolo A, Stati V, Chiefari A, Vottari S, Simmaco M, Ferrarazzo G, Ceriani L, Appetecchia M, Giovanella L.
    Thyroid; 2020 May; 30(5):713-719. PubMed ID: 31973653
    [Abstract] [Full Text] [Related]

  • 5. Initial and Dynamic Risk Stratification of Pediatric Patients With Differentiated Thyroid Cancer.
    Sung TY, Jeon MJ, Lee YH, Lee YM, Kwon H, Yoon JH, Chung KW, Kim WG, Song DE, Hong SJ.
    J Clin Endocrinol Metab; 2017 Mar 01; 102(3):793-800. PubMed ID: 27809646
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N, Dauzier E, Godiris-Petit G, Noullet S, Brocheriou I, Leenhardt L, Buffet C, Menegaux F.
    Langenbecks Arch Surg; 2018 May 01; 403(3):325-332. PubMed ID: 29445865
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the 2015 ATA Guidelines in Patients With Distant Metastatic Differentiated Thyroid Cancer.
    van Velsen EFS, Stegenga MT, van Kemenade FJ, Kam BLR, van Ginhoven TM, Visser WE, Peeters RP.
    J Clin Endocrinol Metab; 2020 Mar 01; 105(3):e457-65. PubMed ID: 31665318
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. DEATH RELATED TO PULMONARY METASTASIS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER.
    Leite AK, Kulcsar MA, de Godoi Cavalheiro B, de Mello ES, Alves VA, Cernea CR, Matos LL.
    Endocr Pract; 2017 Jan 01; 23(1):72-78. PubMed ID: 27749128
    [Abstract] [Full Text] [Related]

  • 12. Differentiated Thyroid Carcinoma Long-Term Prognostic Factors.
    Luis PO, Lucía MA, Hugo RC, Ramiro RM, Stalin CQ.
    Int J Surg Oncol; 2024 Jan 01; 2024():1067447. PubMed ID: 39291250
    [Abstract] [Full Text] [Related]

  • 13. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation.
    Shen FC, Hsieh CJ, Huang IC, Chang YH, Wang PW.
    Thyroid; 2017 Apr 01; 27(4):531-536. PubMed ID: 28007013
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
    van Velsen EFS, Visser WE, Stegenga MT, Mäder U, Reiners C, van Kemenade FJ, van Ginhoven TM, Verburg FA, Peeters RP.
    Thyroid; 2021 Jul 01; 31(7):1041-1049. PubMed ID: 33487121
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
    Kelly A, Barres B, Kwiatkowski F, Batisse-Lignier M, Aubert B, Valla C, Somda F, Cachin F, Tauveron I, Maqdasy S.
    PLoS One; 2019 Jul 01; 14(8):e0221298. PubMed ID: 31425569
    [Abstract] [Full Text] [Related]

  • 18. Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea.
    Lee SG, Lee WK, Lee HS, Moon J, Lee CR, Kang SW, Jeong JJ, Nam KH, Chung WY, Jo YS, Lee J.
    Thyroid; 2017 Feb 01; 27(2):174-181. PubMed ID: 27750028
    [Abstract] [Full Text] [Related]

  • 19. RISK FACTORS FOR NONREMISSION AND PROGRESSION-FREE SURVIVAL AFTER I-131 THERAPY IN PATIENTS WITH LUNG METASTASIS FROM DIFFERENTIATED THYROID CANCER: A SINGLE-INSTITUTE, RETROSPECTIVE ANALYSIS IN SOUTHERN CHINA.
    Chen P, Feng HJ, Ouyang W, Wu JQ, Wang J, Sun YG, Xian JL, Huang LH.
    Endocr Pract; 2016 Sep 01; 22(9):1048-56. PubMed ID: 27124694
    [Abstract] [Full Text] [Related]

  • 20. Neck Ultrasound in Patients with Follicular Thyroid Carcinoma.
    Segkos K, Porter K, Senter L, Ringel MD, Nabhan FA.
    Horm Cancer; 2018 Dec 01; 9(6):433-439. PubMed ID: 30088223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.